The parenteral packaging market is expected to grow from USD 13.39 billion in 2025 to USD 20.12 billion by 2034, with a CAGR of 4.63%. The rising demand for pharmaceutical products worldwide is driving the need for parenteral packaging.
Parenteral Packaging Market Key Players
Latest Announcements by Industry Leader
- In May 2025, Managing Partner and Head of Asia at Novo Holdings, Amit Kakar, expressed, "Our investment in SCHOTT Poonawalla reflects our conviction in the strategic importance of high-quality drug delivery systems and the critical role India plays in the global pharmaceutical supply chain. We look forward to supporting SCHOTT Poonawallas next phase of growth alongside TPG and SCHOTT Pharma and helping expand its global footprint while ensuring a resilient and sustainable supply of essential packaging solutions."
New Advancements in the Market
- In January 2025, SGD Pharma announced the launch of glass vials that create a barrier coating to preserve the integrity of the sensitive therapeutic product.
- In May 2025, Novo Holdings announced its investment in SCHOTT Poonawalla, which is Indias leading provider of high-quality drug containment and delivery solutions for injectable pharmaceuticals, alongside TPG Growth, the middle market and growth equity platform of global alternative asset management firm TPG.
Become a valued research partner with us, please feel free to contact us at sales@towardspackaging.com
